call
today
update
information
potential
financial
actual
operator
statements
expenses
development
using
revenue
solution
loss
filing
technology
devices
data
memory
approval
software
phase
bookings
adoption
trial
clinical
collaboration
evening
patients
architecture
treatment
dose
enterprise
disease
study
studies
cloud
dosing
cancer
afternoon
doses
tonight
dram
discuss
available
differ
multiple
filed
mobile
patient
presented
marketable
clinic
deployments
chemotherapy
wafer
analog
placebo
approved
date
deferred
user
partner
treated
trials
computing
therapy
gaap
liver
users
obligation
advanced
design
providers
hardware
ecosystem
physicians
desktop
servers
architectures
tumors
gene
customers
generation
features
equivalents
receive
storage
networking
security
monetization
foundry
inhibitor
may
current
revenues
drug
risks
license
milestones
efficacy
submitted
scientific
protocol
preclinical
cohort
wired
tolerability
mutations
research
registration
apps
cohorts
cell
pivotal
utility
tumor
report
regulatory
version
application
published
fab
endpoint
use
received
agreement
released
device
toxicity
endpoints
ramp
conference
applications
file
partners
recognized
milestone
commercialization
candidate
randomized
mainframe
number
release
filings
enrolled
validation
billings
linearity
regimen
provide
materially
installed
royalties
initiate
tolerated
novel
enterprises
server
pipeline
communications
enrolling
treat
investigators
pcs
ios
thank
documents
partnership
inhibitors
foundries
survival
prostate
monotherapy
provider
unmet
royalty
node
advance
conferences
fibrosis
public
reconciliation
conducted
breast
believe
approximately
organizations
designed
solutions
content
oncology
routing
submission
regimens
mutation
milligrams
large
subject
enable
wireless
advancing
future
uncertainties
companies
transition
megawatts
barrels
semiconductor
intellectual
cells
graphics
salesforce
routers
case
requirements
technologies
oled
sites
option
suite
tablet
website
currently
demonstrated
middleware
joining
intangibles
audio
notebook
vascular
required
patent
attach
distributed
wafers
ovarian
decrease
compensation
webcast
deals
discussions
compound
broadcast
metastatic
paid
review
cause
recognition
enroll
duration
iphone
firewall
subjects
